483 Daiwa Pharmaceutical Jul 2017

483 Daiwa Pharmaceutical Jul 2017

Djamila Harouaka FDA$119.00 - Available Now

FDA investigators audited the Daiwa Pharmaceutical - Toyama, Japan facility and issued inspectional observations (via FDA 483) on 21 Jul 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 21 Jul 2017
  • Location: Toyama, Japan
  • FEI: 3002806782
Add To Cart